EI
OKYO

EFG International’s OKYO Pharma OKYO Stock Holding History

EFG International’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39K Hold
923
– – ﹤0.01% 1068
2026
Q1 		$1.49K Hold
923
– – ﹤0.01% 1013
2025
Q4 		$1.91K Buy
+923
New +$2K ﹤0.01% 849

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

EFG International's OKYO Position: Q2 2026 in Review

EFG International held its OKYO Pharma (OKYO) position steady in Q2 2026 at 923 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

EFG International first reported a position in OKYO in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.91K in Q4 2025. 19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

  • EFG International held 923 shares of OKYO Pharma worth $1.39K as of Q2 2026.
  • EFG International left its OKYO Pharma share count unchanged in Q2 2026.
  • OKYO Pharma made up ﹤0.01% of EFG International's portfolio in Q2 2026, its #1068 holding.
  • EFG International first reported a position in OKYO Pharma in Q4 2025 and has held it in 3 quarters since.
  • EFG International's OKYO Pharma position peaked at $1.91K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.